Area of research
Oncology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations, and Cancer Genomics and Diagnostics.
Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis
Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction
Linking Skin and Joint Inflammation in Psoriatic Arthritis through Shared CD8 <sup>+</sup> T Cell Clones
Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes
Enriched circulating and tumor-resident TGF-β <sup>+</sup> regulatory B cells in patients with melanoma promote FOXP3 <sup>+</sup> Tregs
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies